Your browser doesn't support javascript.
loading
The Relationship between Fatigue and Cytokine Levels in Patients with Acute Myeloid Leukemia.
Khosravi, Malihe; Taghvaye Masoumi, Hamidreza; Gholami, Kheirollah; Vaezi, Mohammad; Hadjibabaei, Molouk; Ghavamzadeh, Ardeshir.
Afiliación
  • Khosravi M; Hematology-Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Taghvaye Masoumi H; Hematology-Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Gholami K; Hematology-Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Vaezi M; Hematology-Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Hadjibabaei M; Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
  • Ghavamzadeh A; Hematology-Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Int J Hematol Oncol Stem Cell Res ; 12(4): 318-321, 2018 Oct 01.
Article en En | MEDLINE | ID: mdl-30774833
ABSTRACT

Background:

Cancer-related fatigue (CRF) is a very prominent complaint and disabling symptom in cancer patients probably influenced by endogenous cytokines. But, the published data on this subject are limited. We explored the relationship of cytokines such as tumor necrosis factor (TNF-α) and interleukin-6 (IL-6) with fatigue in patients with AML. Materials and

Methods:

This study was performed on 45 patients (25 men, 20 women) with newly diagnosed AML. We examined fatigue in these patients with validated questionnaire. Simultaneously, blood samples were obtained for quantitative measurement of IL-6 and TNF-α.

Results:

Our results showed a positive correlation between fatigue and circulating levels of IL-6 (P=0.004, R=0.416).

Conclusion:

Many patients with AML experienced severe fatigue before the onset of treatment, which is not related to their hemoglobin (Hb) levels. Cytokine levels may be beneficial markers in resistance to fatigue, but further studies are needed before considering targeted therapies as a treatment for CRF.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Int J Hematol Oncol Stem Cell Res Año: 2018 Tipo del documento: Article País de afiliación: Irán

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Int J Hematol Oncol Stem Cell Res Año: 2018 Tipo del documento: Article País de afiliación: Irán
...